Alternative Mitochondrial Functions In Cell Physiopathology: Beyond Atp Production. by Kowaltowski, A J
241
Braz J Med Biol Res 33(2) 2000
Alternative mitochondrial functionsBrazilian Journal of Medical and Biological Research (2000) 33: 241-250
ISSN 0100-879X
Alternative mitochondrial functions
in cell physiopathology: beyond ATP
production
Departamento de Patologia Clínica, Faculdade de Ciências Médicas,
Universidade Estadual de Campinas, Campinas, SP, Brasil
A.J. Kowaltowski
Abstract
It is well known that mitochondria are the main site for ATP genera-
tion within most tissues. However, mitochondria also participate in a
surprising number of alternative activities, including intracellular
Ca2+ regulation, thermogenesis and the control of apoptosis. In addi-
tion, mitochondria are the main cellular generators of reactive oxygen
species, and may trigger necrotic cell death under conditions of
oxidative stress. This review concentrates on these alternative mito-
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In order to continuously generate ATP,
mitochondria remove electrons from reduced
substrates and transfer them to oxygen
through a specialized group of respiratory
complexes. According to Peter Mitchells
findings (1), the energy generated in this
process is used to move protons from the
mitochondrial matrix to the mitochondrial
intermembrane space in a process known as
proton pumping. Since the inner mitochon-
drial membrane is normally highly imperme-
able to protons, respiratory chain-generated
proton pumping produces a proton potential
across the inner mitochondrial membrane,
which is used by the mitochondrial ATP
synthase to generate ATP from ADP plus
inorganic phosphate. ATP is thus produced
in a highly conservative fashion, a process
essential for cell physiology.
Although ATP synthesis is the primary
role of mitochondria, it is not the only func-
tion of these organelles. Indeed, many stud-
ies have shown that mitochondria present a
surprising diversity of activities within the
cell. This is compatible with the recent find-
ing that mitochondria may have originated at
essentially the same time as the nuclear com-
ponent of the eukaryotic cell rather than in a
separate, subsequent event (2). This review
focuses on four of the main alternative mito-
chondrial functions and recent findings about
them. The mitochondrial activities discussed
here include heat generation, intracellular
Ca2+ regulation, reactive oxygen species gen-
eration and the triggering of cell death.
Thermogenesis
Newborn, cold adapted and hibernating
mammals have the ability to maintain their
body temperature in a manner independent
of shivering, but secondary to an adrenergi-
cally stimulated increase in respiration (3).
Adrenergic stimuli in these animals promote
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a remarkable increase in blood flow to brown
adipose tissue, which is the main tissue re-
sponsible for non-shivering thermogenesis
(4). Interestingly, mitochondria within brown
adipose tissue cells behave rather differently
from those in other tissues: ATP synthesis is
limited, the membrane potential is reduced
and respiratory rates are increased (5,6). This
suggests that these mitochondria have inner
membranes with a higher permeability to
protons. In fact, brown adipose tissue mito-
chondria contain the uncoupling protein-1
(UcP1), a 32-kDa inner membrane protein
which stimulates proton conductance (7).
Ironically, UcP1 itself, when isolated and
incorporated into liposomes, does not trans-
port protons. Rather, it is an anion trans-
porter, and promotes mitochondrial uncou-
pling by transporting fatty acid anions across
the inner mitochondrial membrane in a man-
ner regulated by purine nucleotides (8,9).
These fatty acids then protonate and flip-
flop electroneutrally across the lipid phase
of the inner mitochondrial membrane, lead-
ing to increased mitochondrial proton per-
meability (see Scheme 1). As a consequence
of this increased inner mitochondrial perme-
ability to protons, part of the energy stored as
membrane potential generated by the mito-
chondrial respiratory chain is released in the
form of heat, when protons return to the
mitochondrial matrix.
UcP1 was discovered in the 1970s, and
was thought to be the only protein of this
kind for over 20 years, until Vercesi and co-
workers (10) described the existence of an
uncoupling protein in mitochondria isolated
from potato tubers, and later in a variety of
other plant mitochondria (11). This uncou-
pling protein, known as plant uncoupling
mitochondrial protein (PUMP) functions
similarly to UcP1 (12), and is involved in the
heat generation necessary for fruit ripening
(13).
Interestingly, in addition to PUMP, plant
mitochondria may also contain the alterna-
tive oxidase, a mitochondrial respiratory path-
way from ubiquinol to oxygen which does
not promote proton pumping, and is, there-
fore, dissipative (14; see Scheme 1). The
mitochondrial alternative oxidase is involved
in the heat generation of thermogenic plants
such as the skunk cabbage, and can be inhib-
ited by salicylhydroxamic acid (14). The
presence of two dissipative pathways in plants
is curious, and raises questions regarding the
regulation of these pathways. Although the
contribution of each pathway under differ-
ent conditions of plant thermogenesis has
not been well established, it now seems clear
that these pathways do not operate simulta-
neously (15).
Following the characterization of PUMP,
three sequences corresponding to mamma-
lian mitochondrial proteins homologous to
UcP1 were found to be expressed (in quanti-
ties much lower than UcP1) ubiquitously
(UcP2; 16) in skeletal muscle (UcP3; 17,18)
or in the brain (UcP4; 19). Recent studies
have determined that UcP2 and UcP3 are
capable of translocating fatty acids, con-
firming that they are uncoupling proteins
(20). The exact relevance of these newly
characterized mammalian uncoupling pro-
teins is still not completely clear, but some
interesting studies suggest that they may be
involved in the control of body weight. In
this sense, it has been shown that UcP3 gene
intermembrane space
alt. ox. resp. chain UcP






Scheme 1 - Energy-dissipating
pathways in mitochondria. The
mitochondrial respiratory chain
(resp. chain), located in the inner
mitochondrial membrane, re-
duces oxygen to water to gener-
ate a proton gradient, essential
for ATP synthesis. However,
oxygen reduction may also be
promoted by the plant mitochon-
drial alternative oxidase (alt. ox.)
in a dissipating process which
may not generate a proton gradi-
ent. The proton gradient is de-
creased by the activity of uncou-
pling proteins (UcP), which trans-
locate fatty acid anions from the
mitochondrial matrix to the cyto-
plasmic surface of the inner mi-
tochondrial membrane. Fatty
acid anions then combine with
protons, and flip-flop electroneu-
trally across the lipid bilayer.
mitochondrial matrix
243
Braz J Med Biol Res 33(2) 2000
Alternative mitochondrial functions
expression is stimulated by a high-fat diet
(21), and reduced by dietary restriction
(22,23). Reduced UcP3 expression is also
linked to obesity-related non-insulin depend-
ent diabetes (24). The relationship between
UcP2 and body weight is suggested by the
demonstration that leptin, which reduces
body weight by decreasing food intake and
increasing thermogenesis, induces UcP2 gene
expression (25).
Regulation of intracellular Ca2+
homeostasis
Cytosolic Ca2+ levels are maintained at
concentrations approximately 10,000 times
lower than the Ca2+ concentrations in the
extracellular medium (for review, see 26,27).
This process is controlled mainly by plasma
membrane and endoplasmic reticulum Ca2+
ATPases and by Ca2+ exchanges in a process
that requires energy. Clearly, if mitochon-
dria become dysfunctional and ATP synthe-
sis is impaired, cellular Ca2+ homeostasis
will be affected.
In addition to providing the energy nec-
essary for intracellular Ca2+ regulation, mi-
tochondria themselves participate in the con-
trol of intracellular Ca2+ concentrations. In
the presence of a membrane potential, cat-
ions can be accumulated in mitochondria
down the membrane potential, as long as
there is a transport pathway. Thus, mito-
chondria from vertebrates are capable of
actively accumulating Ca2+ ions, since they
possess a Ca2+ uniporter (for review, see
26,27).
Ca2+ uptake by mitochondria depends on
the presence of a membrane potential which
provides the driving force for accumulation
(the negative intramitochondrial charge; see
Scheme 2), and is inhibited by submicromolar
concentrations of ruthenium red, an inhibi-
tor of the Ca2+ uniporter (26,27). Ruthenium
red also inhibits a second mechanism for
Ca2+ uptake into mitochondria through the
rapid Ca2+ uptake mode (RaM; 28), although
10 times higher concentrations are required.
The channel which promotes RaM Ca2+ up-
take has not been characterized, and may be
the Ca2+ uniporter itself, operating under a
more rapid conductivity mode. However,
the distinct sensitivity of RaM to inhibitors
of the Ca2+ uniporter and mainly the lack of
sensitivity to Mg2+, which inhibits Ca2+ up-
take via the Ca2+ uniporter (28), suggest that
RaM may involve an independent channel.
The total Ca2+ accumulation capacity of
mitochondria can be quite high, as long as
inorganic phosphate is accumulated in par-

















Scheme 2 - Mitochondrial Ca2+
transport. Mitochondrial Ca2+ in-
flux is mediated by the inner
membrane uniporter or RaM and
driven by the proton electro-
chemical potential. Ca2+ efflux
is promoted by the Ca2+/2H+
and Ca2+/2Na+ (or Ca2+/3Na+)
exchange. Na+ redistribution is
maintained by the Na+/H+ anti-
porter. resp. chain, Respiratory
chain.
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allel, to compensate for changes in the mito-
chondrial pH gradient across the inner mito-
chondrial membrane, and the inner mem-
brane is not permeabilized by the mitochon-
drial permeability transition (MPT) (see dis-
cussion below). Although accumulation ca-
pacity is high, the affinity for mitochondrial
Ca2+ uptake is low, requiring extramitochon-
drial Ca2+ concentrations of at least 200-300
nM (26,27). Because of this low affinity of
the mitochondrial Ca2+ uptake and the typi-
cal cytosolic free Ca2+ concentrations under
resting conditions (<100 nM), mitochondrial
Ca2+ uptake was believed not to occur inside
the cell under physiological conditions. This
hypothesis has now been overruled by ob-
servations of Ca2+ uptake into mitochondria
within intact cells (29-31). It is possible that
mitochondria take up Ca2+ during periodic
increases in intracellular Ca2+ concentrations
(Ca2+ spikes; 29), or through a close interac-
tion with the endoplasmic reticulum Ca2+
release pathways (30) and plasma membrane
channels (32).
Confirming that Ca2+ uptake by mito-
chondria is important for cell function, mito-
chondria have developed an elaborate Ca2+
release system composed of two transport-
ers: the Ca2+/2H+ exchange, and the Ca2+/
2Na+ (or Ca2+/3Na+; 33) exchange. As shown
in Scheme 2, Ca2+ efflux is energetically
uphill, and thus dissipates the mitochondrial
proton gradient. Ca2+ efflux through these
carriers is 500-1000 times slower than Ca2+
uptake through the uniporter, and can be
inhibited by respiratory inhibitors and un-
couplers (Ca2+/2H+ exchange) or diltiazem,
verapamil, clonazepam, amiodarone, Mg2+
and tetraphenylphosphonium (Ca2+/2Na+
exchange; for reviews, see 26,27).
The physiological role of Ca2+ may be
related to the regulation of respiratory activ-
ity. The presence of Ca2+ in the mitochon-
drial matrix stimulates respiration by affect-
ing three mitochondrial enzymes: pyruvate
dehydrogenase phosphatase, NAD+-linked
isocitrate dehydrogenase and 2-oxoglutarate
dehydrogenase. This enzymatic activation
justifies the enhanced citric acid cycle activ-
ity and respiratory rates observed in tissues
upon adrenergic stimulation, which leads to
elevated intracellular Ca2+ concentrations
(34).
Although the presence of approximately
1 µM Ca2+ in the mitochondrial matrix has
the beneficial effect of stimulating respira-
tory activity, intramitochondrial Ca2+ must
be carefully regulated within the cell, since
excessive mitochondrial Ca2+ accumulation
may lead to a nonselective inner membrane
permeabilization, known as mitochondrial
permeability transition (MPT; see 35-37).
MPT is a Ca2+-triggered permeabilization of
the inner mitochondrial membrane to pro-
tons, ions and solutes of up to 1500 kDa. In
isolated mitochondria, the Ca2+ quantities
necessary for MPT triggering vary widely
with distinct experimental conditions and
from one tissue to another. MPT is thus more
likely to occur (or occurs in the presence of
smaller Ca2+ loads) in the presence of MPT
inducers such as inorganic phosphate, pyri-
dine nucleotide oxidants and dithiol reagents.
On the other hand, ADP, Mg2+, antioxidants
and cyclosporin A (known as a specific MPT
inhibitor) prevent MPT. In vitro, mitochon-
drial membrane permeabilization secondary
to MPT results in a cyclosporin-A sensitive
drop in mitochondrial membrane potential,
and the release of Ca2+ accumulated previ-
ously, a process reversible through Ca2+ che-
lation within a few minutes after its onset. In
isotonic media, MPT also results in colloi-
dosmotic swelling of isolated mitochondria
due to the high protein content of the mito-
chondrial matrix. Undoubtedly, MPT occur-
ring under these conditions results in irre-
versible mitochondrial dysfunction (see fur-
ther discussion under Triggering cell
death). However, the characteristics of MPT
under distinct experimental conditions are
very variable, and a more selective (<300
kDa) low-conductance mode of the per-
meability transition has been observed (for
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review, see 38). According to the model
devised by Ichas and Mazat (38), the low
conductance mode of MPT does not involve
mitochondrial swelling, is fully reversible
upon matrix acidification secondary to the
mitochondrial permeabilization to protons,
and may be a mechanism through which
Ca2+ is quickly released from the mitochon-
drial matrix. In the intact cell, low-conduc-
tance MPT pores may participate in the regu-
lation of cytoplasmic Ca2+ signals (38,39).
Reactive oxygen species (ROS)
generation
As a by-product of electron transport, a
small amount of molecular oxygen (O2) un-
dergoes monoelectronic reduction at inter-
mediate steps of the mitochondrial respira-
tory chain, resulting in the generation of the
superoxide radical (O2-·). This small but
continuous electron leak makes mitochon-
dria the main generation site for reactive
oxygen species within most cells. Catalyzed
by intramitochondrial superoxide dismutase,
O2-· may form hydrogen peroxide (H2O2),
and subsequently hydroxyl radicals (OH· -
formed through the Fe2+-dependent Fentons
reaction) and other ROS (see Scheme 3 and
Refs. 37,40).
Normally, respiratory-chain generated
ROS are detoxified by the efficient mito-
chondrial antioxidant systems (see Scheme
3 and Ref. 40 for review), and do not cause
any permanent damage to mitochondria.
However, under nonphysiological condi-
tions, or over time, mitochondrially gener-
ated ROS may lead to both mitochondrial
and cellular damage. As an example, Ca2+-
triggered MPT, which is an early step in
some conditions leading to cell death, is a
result of mitochondrial oxidative stress (for
reviews, see 37,40). Also, glutamate neuro-
toxicity mediated by excessive stimulation
of N-methyl-D-aspartate receptors occurs
secondarily to excessive mitochondrial Ca2+
uptake and oxidative stress (41). Finally,
many important results of mitochondrial oxi-
dative stress may be observed during aging,
when damage to mitochondrial DNA accu-
mulates over time, and may result in alter-
ations in the synthesis of components of the
respiratory chain (42).
Monoelectronic reduction of oxygen re-
sulting in mitochondrial ROS generation
occurs mainly at the level of complexes I and
III of the respiratory chain, most probably by
donation of an electron from intermediately
reduced forms of ubiquinones (43). Since
complex IV is not an important site for O2-·
generation, mitochondria must not necessar-
ily respire to generate ROS. In fact, certain
respiratory inhibitors such as antimycin A
may increase mitochondrial ROS generation
as they lead to an accumulation of intermedi-
ately reduced ubiquinones. Other conditions
that favor mitochondrial ROS generation are
high membrane potentials, hyperoxia, ex-














Scheme 3 - Mitochondrial gen-
eration of ROS. The respiratory
chain (resp. chain) produces su-
peroxide radicals (O2-·), which
generate hydrogen peroxide
(H2O2) and hydroxyl radicals
(HO·). Mitochondrial nitric oxide
synthase (NOS) produces nitric
oxide (NO·), which combines
with O2-· to generate peroxini-
trite (ONOO-). All these ROS
may cause mitochondrial and
cellular damage if present in ex-
cess. MPT, Mitochondrial per-
meability transition.
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cessive Ca2+ uptake and anoxia/reoxygena-
tion (for review, see 40). Both increased
cytosolic Ca2+ levels and anoxia/reoxygena-
tion of mitochondria occur under conditions
of ischemia/reperfusion in vivo. Indeed, re-
perfusion injury has been closely associated
with mitochondrial oxidative stress and MPT
(44,45).
In addition to producing O2-· through
electron leakage in the respiratory chain,
mitochondria also produce nitric oxide (NO·)
through the activity of a constitutive nitric
oxide synthase similar to the inducible cellu-
lar nitric oxide synthase. NO· levels regulate
mitochondrial respiratory activity, but it is
not yet known if this is the principal function
of mitochondrial NO· (46).
Triggering cell death
Not surprisingly, mitochondrial dysfunc-
tion and consequent cellular ATP depletion
can result in cell death. Indeed, necrotic cell
death under conditions such as ischemia/
reperfusion is strongly inhibited by prevent-
ing associated mitochondrial alterations, sug-
gesting that mitochondrial dysfunction is the
primary trigger for cell death under these
conditions (44,45,47). Mitochondrial dys-
functions which may potentially lead to ne-
crosis include MPT, respiratory inhibition,
uncoupling between respiration and oxida-
tive phosphorylation, and excessive ROS
generation. Excessive ROS generation by
mitochondria may contribute to necrotic cell
death even if cellular ATP is maintained by
affecting intracellular Ca2+ homeostasis (41).
However, mitochondrially triggered cell
death is not always necrotic. Recent evi-
dence has identified these organelles as regu-
lators of the highly complex process of en-
ergy dependent apoptotic cell death (see
Scheme 4). Two mitochondrial intermem-
brane-space proteins, cytochrome c and the
apoptosis inducing factor (AIF), have been
shown to migrate from a mitochondrial to a
cytosolic location shortly before hallmarks
of apoptosis are observed (48,49). Also, mi-
croinjection of both proteins into healthy
cells results in the induction of apoptosis
(50,51). In addition to cytochrome c and
AIF, mitochondria contain pro-caspase 9,
pro-caspase 3 and pro-caspase 2 (52,53)











Scheme 4 - Mitochondria can
trigger cell death. Intact mito-
chondria contain cytochrome c
(circles) and the apoptosis induc-
ing factor (AIF, lines) in the inter-
membrane space. AIF is re-
leased from mitochondria after
the latter undergo nonselective
inner membrane permeabiliza-
tion secondary to MPT, which
results in mitochondrial swelling
and outer membrane disruption.
Cytochrome c may be released
into the cytosol after MPT, upon
Bax targeting to mitochondria or
treatment with Ca2+. Once in
the cytosol, both cytochrome c
and AIF trigger apoptosis. MPT
may also promote necrosis,
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cleaved, act as aspartate-specific proteases
that initiate the apoptotic cascade.
Further evidence that mitochondria par-
ticipate in apoptosis is provided by the loca-
tion of Bcl-2 family proteins within the cell.
bcl-2 was originally identified as a gene
related to oncogenesis in B-cell lympho-
cytes, and later found to express a protein
(Bcl-2) which is part of a family of proteins
presenting both anti- and pro-apoptotic ac-
tivities. Bcl-2 itself is predominantly located
on the outer mitochondrial membrane, and
its main antiapoptotic effect seems to be the
inhibition of mitochondrial cytochrome c
and AIF release (48,49). On the other hand,
pro-apoptotic Bcl-2 family proteins such as
Bax and Bid are primarily cytosolic, and
upon apoptotic stimuli assume a mitochon-
drial location, an event which coincides with
the release of mitochondrial cytochrome c
(54,55).
Although the latest evidence has been
almost unanimous in showing that mitochon-
dria have an important role in the control of
apoptosis, the exact mechanisms by which
mitochondria promote this regulation are not
yet fully understood. As an example, it seems
clear that the occurrence of MPT in vitro
promotes the release of mitochondrial cyto-
chrome c, but it is still controversial if this is
the primary mechanism of cytochrome c re-
lease within cells. Also, the mechanism by
which Bcl-2 family proteins interact with
mitochondria and promote or prevent the
release of cytochrome c has not been well
established. These and other still unresolved
points of interest should be further investi-
gated within the next few years.
In agreement with studies showing a role
for mitochondria in the initial steps of both
necrosis and apoptosis, mitochondrially ac-
tive drugs have been shown to be cardiopro-
tective. Of great interest in this line of study
is the evidence that openers of the mitochon-
drial (but not plasma membrane) ATP-in-
hibited K+ channels, such as diazoxide, pres-
ent cardioprotective effects. In addition, 5-
OH decanoate, a specific mitochondrial K+
channel inhibitor, prevents ischemic precon-
ditioning and the cardioprotective effects of
K+ channel openers (56). These interesting
experiments show that the increased flux of
K+ into mitochondria through the ATP-sen-
sitive K+ channel is cytoprotective. Since the
primary effect of K+ influx is to promote a
small increase in mitochondrial volume
(which does not result in outer mitochon-
drial membrane rupture), cardioprotection
promoted by diazoxide may be the result of
increased ß oxidation of fatty acids and res-
piratory activity secondary to increased mi-
tochondrial volume (57).
Inhibitors of the mitochondrial perme-
ability transition are also cytoprotective in
various in vivo and in vitro cell death models
(44,45,47). It is believed that these condi-
tions lead to intracellular Ca2+ increases,
with excessive mitochondrial Ca2+ uptake,
oxidative stress and MPT. Preventing MPT
avoids ATP depletion secondary to mito-
chondrial dysfunction, and protects from
necrotic cell death under these conditions.
Final remarks
As summarized here, mitochondria pres-
ent a variety of important functions in addi-
tion to producing ATP. As an example, mito-
chondria present regulated pathways that pro-
mote energy dissipation, such as the mito-
chondrial uncoupling proteins and the alter-
native oxidase, which seem to present the
main function of promoting nonshivering
thermogenesis. Thermogenesis is ultimately
achieved when the chemical energy con-
tained in reduced substrates is released, but
not explored for ATP synthesis.
It is also well established that mitochon-
dria actively take up Ca2+ within intact cells,
and that this Ca2+ uptake may both regulate
mitochondrial respiratory parameters and
influence cytosolic Ca2+ transients. Mito-
chondrial Ca2+ uptake occurs through the
Ca2+ uniporter or RaM, while Ca2+ release
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occurs through exchange with Na+ and H+
or, eventually, the low-conductance MPT
pore.
In addition, mitochondria constantly pro-
duce ROS, and have thus developed an effi-
cient antioxidant system. However, imbal-
ances in ROS generation or detoxification
systems may result in a condition of oxida-
tive stress. Under these conditions, damage
to both mitochondrial and cellular constitu-
ents may occur. Functional mitochondrial
impairment leading to cellular ATP deple-
tion is an initial step in many models for
necrotic cell death. Mitochondria may also
trigger ATP-dependent apoptotic cell death
through the release of pro-apoptotic proteins
from the mitochondrial intermembrane space
into the cytosol. These findings agree with
the characterization of the cytoprotective ef-
fects of mitochondrially active drugs (44,
45,47).
Thus, alternative mitochondrial activi-
ties, in addition to ATP synthesis, are impor-
tant factors in cell physiology, and may tip
the balance between cell survival and death.
Further knowledge about these alternative
mitochondrial activities will contribute to
the development of more efficient mitochon-
drially targeted drugs capable of better pre-
venting ischemic injury. The modulation of
mitochondrial activities may also be effec-
tive in the treatment of obesity and diabetes.
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